Brokerages Set Progyny, Inc. (NASDAQ:PGNY) PT at $25.42

Progyny, Inc. (NASDAQ:PGNY) has earned a consensus recommendation of “Hold” from the thirteen brokerages that are currently covering the stock, MarketBeat.com reports. Eight analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $25.42.

Several brokerages have weighed in on PGNY. Canaccord Genuity Group dropped their price objective on shares of Progyny from $18.00 to $17.00 and set a “hold” rating for the company in a research note on Wednesday, November 13th. BTIG Research downgraded shares of Progyny from a “buy” rating to a “neutral” rating in a research report on Wednesday, August 7th. Canaccord Genuity Group downgraded Progyny from a “buy” rating to a “hold” rating and reduced their price target for the stock from $37.00 to $24.00 in a research report on Wednesday, August 7th. JMP Securities cut Progyny from an “outperform” rating to a “market perform” rating in a report on Thursday, September 19th. Finally, Jefferies Financial Group reduced their target price on Progyny from $31.00 to $24.00 and set a “buy” rating on the stock in a report on Thursday, September 19th.

Institutional Investors Weigh In On Progyny

Several hedge funds and other institutional investors have recently made changes to their positions in PGNY. Disciplined Growth Investors Inc. MN boosted its position in Progyny by 56.5% in the third quarter. Disciplined Growth Investors Inc. MN now owns 826,726 shares of the company’s stock valued at $13,856,000 after buying an additional 298,314 shares in the last quarter. Barclays PLC boosted its holdings in shares of Progyny by 530.4% during the 3rd quarter. Barclays PLC now owns 706,157 shares of the company’s stock valued at $11,835,000 after acquiring an additional 594,140 shares in the last quarter. Y Intercept Hong Kong Ltd bought a new stake in Progyny during the 3rd quarter worth $469,000. Wellington Management Group LLP increased its holdings in Progyny by 4.0% in the 3rd quarter. Wellington Management Group LLP now owns 430,300 shares of the company’s stock worth $7,212,000 after purchasing an additional 16,638 shares in the last quarter. Finally, Wolverine Trading LLC raised its position in Progyny by 131.5% in the third quarter. Wolverine Trading LLC now owns 19,677 shares of the company’s stock valued at $331,000 after purchasing an additional 11,177 shares during the last quarter. 94.93% of the stock is owned by institutional investors.

Progyny Stock Down 1.5 %

Shares of NASDAQ:PGNY opened at $13.77 on Friday. Progyny has a 12-month low of $13.39 and a 12-month high of $42.08. The business has a 50 day moving average of $17.30 and a 200-day moving average of $23.24. The stock has a market cap of $1.17 billion, a PE ratio of 23.74, a P/E/G ratio of 1.44 and a beta of 1.44.

Progyny (NASDAQ:PGNY) last released its quarterly earnings results on Tuesday, November 12th. The company reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.37 by ($0.26). Progyny had a return on equity of 11.36% and a net margin of 5.03%. The firm had revenue of $286.63 million for the quarter, compared to analyst estimates of $296.85 million. During the same period in the previous year, the business posted $0.16 earnings per share. The business’s revenue for the quarter was up 2.0% on a year-over-year basis. Equities research analysts expect that Progyny will post 0.64 earnings per share for the current year.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.